Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

Common Shareholders and Diluted Earnings per Common Share (Amounts in Millions, except per share figures) Six months ended June 30, 2009 (unaudited) ----------- Special, Purchase Merger and Accounting Acquisition- Other As As Adjust- Related Specified Reconciled Reported ments Items Items (1) -------- ----- ----- ----- --- Net sales $9,040 $- $- $- $9,040 Cost of sales 3,019 (256) (7) - 2,756 Selling, general and administrative 3,119 (3) - - 3,116 Research and development 1,667 (5) (2) - 1,660 Other expense/(income), net 194 - - - 194 Special, merger and acquisition-related charges 104 - (104) - - Equity income (770) - - - (770) ----- - - - ----- Income before income taxes 1,707 264 113 - 2,084 Income tax expense/(benefit) 231 (59) (13) - 303 --- ---- ---- - --- Net income $1,476 $205 $100 $- $1,781 ------ ---- ---- -- ------ Preferred stock dividends 75 - - -
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014  Smith & Nephew (LSE:SN, NYSE: ... today announced its entry into the forefoot market ... Repair System. Comprised of three separate repair options, ... ligament repair and reconstruction, a metatarsal osteotomy guide, ... (PIP) fusion, also known as hammer toe correction. ...
(Date:7/31/2014)... 31, 2014 Although RNA-Sequencing is ... first transcriptome-wide analyses appearing around 2008, RNA-Sequencing has ... RNA measurement. In the last several years, assays ... work with smaller input amounts, process degraded RNA, ... samples). On the bioinformatics side, there have been ...
(Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, ... adult stem cell biotechnologies. Currently the company holds ... additional patent applications currently under examination by the U.S. ... two of the most vexing problems in adult stem ... cells are difficult to identify; and they have been ...
(Date:7/30/2014)... July 30, 2014  Decision Resources Group finds ... directors in the United States ... market penetration will be the level of savings ... the expected lower cost to patients. Payers plan ... meet their pricing expectations in order to encourage ...
Breaking Biology Technology:Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... YORK, Aug. 18 Regenicin, Inc. (OTC Bulletin Board: ... announced today that it has completed an initial $3.25 ... worldwide exclusive license to know-how technology controlled by Lonza ... Lonza Group Ltd. (SIX: LONN), one of the world,s ...
... 17 SeqWright Inc., a world-wide leader in custom ... has acquired the Illumina HiSeq 2000 Next Generation Sequencing ... to perform the largest and most complex sequencing studies ... ability to process increased numbers of samples and to ...
... SAN DIEGO, Aug. 17 Imagenetix, Inc. (OTC Bulletin Board: ... June 30, 2010. Net sales decreased 36% for the first quarter ... period of last year.   Net loss for the first quarter ... $415,000 or $.04 per share for the same period of the ...
Cached Biology Technology:Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville 2SeqWright Announces the Addition of Illumina HiSeq 2000 to its Next Generation Sequencing Capabilities 2Imagenetix, Inc. Reports First Quarter 2011 Results 2Imagenetix, Inc. Reports First Quarter 2011 Results 3
(Date:7/31/2014)... Researchers who studied 100 twin pairs have identified a gene ... less than six hours of sleep per night. The ... effects of sleep deprivation. , Results show that a participant ... had an average nightly sleep duration of only five hours, ... twin, who slept for about six hours and five minutes ...
(Date:7/31/2014)... from Spain, France, and the U.S. has discovered ... oldest definitive member of the tribe Omaliini that ... and description were made possible through the use ... which allows the detailed study of otherwise invisible ... described in the journal Annals of the ...
(Date:7/31/2014)... exposure to loud noise alters how the brain ... speech sounds, according to neuroscientists at The University ... published this week in Ear and Hearing ... noise-induced hearing loss affects the brain,s recognition of ... all corners of the population, affecting an estimated ...
Breaking Biology News(10 mins):Study of twins discovers gene mutation linked to short sleep duration 2UT Dallas study reveals effect of loud noises on brain 2
... URBANA - When University of Illinois researchers surveyed over 3,500 ... accurately, and overweight and obese men were more likely to ... because the first step in dealing with a weight problem ... U of I professor of food science and human nutrition. ...
... N.Y. Most medical imaging equipment is not designed with ... individuals can be exposed to higher levels of radiation during ... from Rensselaer Polytechnic Institute is the first to calculate exactly ... scan. Research results show the internal organs of obese men ...
... E. Prada, MD of Cincinnati Children,s Hospital and James ... NY were honored as the 2012-2013 recipients of the ... Genetics at the ACMG 2012 Annual Clinical Genetics Meeting ... Genzyme/ACMG Foundation Awards is to support a national training ...
Cached Biology News:Misperception of weight is an important barrier to weight loss 2Obese patients face higher radiation exposure from CT scans -- but new technology can help 2Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced 2
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... 2800mL PYREX Fernbach-style culture flasks have triple ... flask bottom to achieve maximal oxygen transfer ... large marking spot., A wide range of ... including:, Polypropylene colored caps for ease ...
... 400g of purified RNA samples., , This ... of aqueous RNA samples that have been ... phenol/chloroform, silica, oligo dT etc or other ... the necessary components for the stabilization of ...
...
Biology Products: